Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.
Dieli
Francesco
F
Gebbia
Nicola
N
Poccia
Fabrizio
F
Caccamo
Nadia
N
Montesano
Carla
C
Fulfaro
Fabio
F
Arcara
Carlo
C
Valerio
Maria R
MR
Meraviglia
Serena
S
Di Sano
Caterina
C
Sireci
Guido
G
Salerno
Alfredo
A
D004164:Diphosphonates / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D016692:Receptors, Antigen, T-Cell, gamma-delta; D000077211:Zoledronic Acid